Australia · Pharmaceutical Manufacturing
Pharmaceuticals
Biotechnology
Healthcare
Pharmaceutical Manufacturing
Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).
2016
Founded
Pharmaceutical Manufacturing
Industry
Australia
Location
1,604,189
Ranking
600 employees
Size

Get full access to view complete information

© Pubrio 2026